BR112013014940A2 - composições farmacêuticas de inibidores de fator xa seletivos para administração oral - Google Patents

composições farmacêuticas de inibidores de fator xa seletivos para administração oral

Info

Publication number
BR112013014940A2
BR112013014940A2 BR112013014940A BR112013014940A BR112013014940A2 BR 112013014940 A2 BR112013014940 A2 BR 112013014940A2 BR 112013014940 A BR112013014940 A BR 112013014940A BR 112013014940 A BR112013014940 A BR 112013014940A BR 112013014940 A2 BR112013014940 A2 BR 112013014940A2
Authority
BR
Brazil
Prior art keywords
selective
pharmaceutical compositions
oral administration
factor inhibitor
inhibitor pharmaceutical
Prior art date
Application number
BR112013014940A
Other languages
English (en)
Portuguese (pt)
Inventor
Alan Cullen
David C Coughlan
Thomas W Leonard
Original Assignee
Merrion Reserarch Iii Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrion Reserarch Iii Ltd filed Critical Merrion Reserarch Iii Ltd
Publication of BR112013014940A2 publication Critical patent/BR112013014940A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112013014940A 2010-12-15 2011-09-23 composições farmacêuticas de inibidores de fator xa seletivos para administração oral BR112013014940A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42326110P 2010-12-15 2010-12-15
PCT/US2011/052963 WO2012082209A1 (en) 2010-12-15 2011-09-23 Pharmaceutical compositions of selective factor xa inhibitors for oral administration

Publications (1)

Publication Number Publication Date
BR112013014940A2 true BR112013014940A2 (pt) 2016-09-13

Family

ID=46234738

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013014940A BR112013014940A2 (pt) 2010-12-15 2011-09-23 composições farmacêuticas de inibidores de fator xa seletivos para administração oral

Country Status (10)

Country Link
US (1) US20120156294A1 (de)
EP (1) EP2651395A4 (de)
JP (1) JP2013545802A (de)
KR (1) KR20140046395A (de)
CN (1) CN103370051A (de)
AU (1) AU2011341637A1 (de)
BR (1) BR112013014940A2 (de)
CA (1) CA2819108A1 (de)
MX (1) MX2013006877A (de)
WO (1) WO2012082209A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
KR20140026354A (ko) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
EP3250191B1 (de) 2015-01-29 2024-01-17 Novo Nordisk A/S Tabletten mit glp-1-agonisten und magensaftresistentem überzug
CN108148102A (zh) * 2016-12-03 2018-06-12 烟台东诚药业集团股份有限公司 喷雾干燥法制备低水分磺达肝癸钠原料药
KR20190130411A (ko) 2018-05-14 2019-11-22 신일제약주식회사 아픽사반 약제학적 제제 및 그의 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2363123C (en) * 1999-02-22 2011-09-06 Kenneth Iain Cumming Solid oral dosage form containing an enhancer
CA2438707A1 (en) * 2001-02-16 2002-08-22 Akihiro Matsuura Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
US20070212395A1 (en) * 2006-03-08 2007-09-13 Allergan, Inc. Ocular therapy using sirtuin-activating agents
ES2426445T3 (es) * 2006-04-07 2013-10-23 Merrion Research Iii Limited Forma de dosificación oral sólida que contiene un potenciador
TW200950801A (en) * 2008-05-07 2009-12-16 Merrion Res Iii Ltd Compositions of peptides and processes of preparation thereof
NZ591810A (en) * 2008-09-17 2012-12-21 Chiasma Inc Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid
US9089484B2 (en) * 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration

Also Published As

Publication number Publication date
CN103370051A (zh) 2013-10-23
EP2651395A4 (de) 2014-05-07
MX2013006877A (es) 2013-07-05
JP2013545802A (ja) 2013-12-26
AU2011341637A1 (en) 2013-06-20
EP2651395A1 (de) 2013-10-23
CA2819108A1 (en) 2012-06-21
WO2012082209A1 (en) 2012-06-21
KR20140046395A (ko) 2014-04-18
US20120156294A1 (en) 2012-06-21

Similar Documents

Publication Publication Date Title
SMT201600350B (it) Composizioni farmaceutiche
SMT201700008B (it) Composizione farmaceutica
SMT201700095B (is) Composizioni farmaceutiche per inalazione
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
CO6852076A2 (es) Composiciones farmacéuticas inhalables
BR112013017169A2 (pt) composições farmacêuticas de ferro para administração oral
DK3284467T3 (da) Nikotinholdige farmaceutiske sammensætninger
DK3246018T3 (da) Farmaceutisk sammensætning
BR112014003052A2 (pt) composições farmacêuticas
BRPI0918971A2 (pt) tienopirimidinas para composições farmacêuticas
SMT201400069B (it) Formulazione farmaceutica
BRPI1012539A2 (pt) composições farmacêuticas
CO6930367A2 (es) Composiciones farmaceúticas
EE201300005A (et) Ravimkoostis
GT201200303A (es) Formulaciones farmacéuticas
BRPI1007484A2 (pt) composição farmacêutica para administração oral
IT1394400B1 (it) Composizioni farmaceutiche
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
CO6950486A2 (es) Solución para administración oral
DK2815752T3 (da) Oral farmaceutisk sammensætning
CO6801722A2 (es) Composiciones farmacéuticas
BRPI0820198A2 (pt) composições farmacêuticas
SMT201600342B (it) Composizioni farmaceutiche topiche comprendenti mometasone furoato
SMT201500005B (it) Composizione framaceutica inalabile

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]